Literature DB >> 11834837

Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor.

Luciano Di Croce1, Veronica A Raker, Massimo Corsaro, Francesco Fazi, Mirco Fanelli, Mario Faretta, Francois Fuks, Francesco Lo Coco, Tony Kouzarides, Clara Nervi, Saverio Minucci, Pier Giuseppe Pelicci.   

Abstract

DNA methylation of tumor suppressor genes is a frequent mechanism of transcriptional silencing in cancer. The molecular mechanisms underlying the specificity of methylation are unknown. We report here that the leukemia-promoting PML-RAR fusion protein induces gene hypermethylation and silencing by recruiting DNA methyltransferases to target promoters and that hypermethylation contributes to its leukemogenic potential. Retinoic acid treatment induces promoter demethylation, gene reexpression, and reversion of the transformed phenotype. These results establish a mechanistic link between genetic and epigenetic changes during transformation and suggest that hypermethylation contributes to the early steps of carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11834837     DOI: 10.1126/science.1065173

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  202 in total

1.  Dnmt3L is a transcriptional repressor that recruits histone deacetylase.

Authors:  Rachel Deplus; Carmen Brenner; Wendy A Burgers; Pascale Putmans; Tony Kouzarides; Yvan de Launoit; François Fuks
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

2.  Functional characterization of a testis-specific DNA binding activity at the H19/Igf2 imprinting control region.

Authors:  Aaron B Bowman; John M Levorse; Robert S Ingram; Shirley M Tilghman
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

3.  Impairment of p53 acetylation, stability and function by an oncogenic transcription factor.

Authors:  Alessandra Insinga; Silvia Monestiroli; Simona Ronzoni; Roberta Carbone; Mark Pearson; Giancarlo Pruneri; Giuseppe Viale; Ettore Appella; PierGiuseppe Pelicci; Saverio Minucci
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

Review 4.  Targeting the epigenome with bioactive food components for cancer prevention.

Authors:  Thomas Prates Ong; Fernando Salvador Moreno; Sharon Ann Ross
Journal:  J Nutrigenet Nutrigenomics       Date:  2012-02-22

5.  Pancreatic cancer DNMT1 expression and sensitivity to DNMT1 inhibitors.

Authors:  Ang Li; Noriyuki Omura; Seung-Mo Hong; Michael Goggins
Journal:  Cancer Biol Ther       Date:  2010-02-01       Impact factor: 4.742

Review 6.  Epigenetic system: a pathway to malignancies and a therapeutic target.

Authors:  Mitsuyoshi Nakao; Takeshi Minami; Yasuaki Ueda; Yasuo Sakamoto; Takaya Ichimura
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

Review 7.  Beyond genetics--the emerging role of epigenetic changes in hematopoietic malignancies.

Authors:  Oliver Galm; Manel Esteller
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

Review 8.  DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia.

Authors:  Björn Rüter; Pierre W Wijermans; Michael Lübbert
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

9.  Predicting aberrant CpG island methylation.

Authors:  F A Feltus; E K Lee; J F Costello; C Plass; P M Vertino
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

10.  C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells.

Authors:  Estelle Duprez; Katharina Wagner; Heike Koch; Daniel G Tenen
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.